Day 4 from Amsterdam 2023

Patient well-being symposium aims to raise awareness and offer solutions

The importance of considering the psychosocial and emotional impacts suffered by patients with diseases causing vision loss and the relationship between patient satisfaction with care and treatment adherence/persistence were topics addressed by a series of speakers from the United Kingdom in the Sunday afternoon symposium “Patient Well-Being: Time to Take our Heads Out of the […]

Patient well-being symposium aims to raise awareness and offer solutions Read More »

Delving into the distribution of retinal biomarkers for insights on disease aetiology and clinical features

Speakers in a Sunday morning symposium session presented their research investigating the spatial distribution of retinal biomarkers and discussed how the information provides insights about the etiology and clinical features of age-related macular degeneration (AMD) and diabetic eye disease. Leading off the session, Dr Christine A Curcio (United States) described findings from studies done to

Delving into the distribution of retinal biomarkers for insights on disease aetiology and clinical features Read More »

Session on age-related macular degeneration (AMD) covers topics relating to risk factor identification and treatment

Discussing the impact of genetic factors on AMD characteristics and natural history, Steffen Schmitz-Valckenberg (Germany) concluded that according to current knowledge, genetics appears to have a more relevant association with the initial manifestation of AMD and in the early course of the disease as compared to later stages where unspecific degenerative mechanisms may play a

Session on age-related macular degeneration (AMD) covers topics relating to risk factor identification and treatment Read More »

Speakers’ corner proving big hit with attendees

Delegates attending Saturday afternoon’s Speakers’ Corner session on imaging heard colleagues describe interesting cases and findings from prospective and retrospective clinical studies evaluating the performance of different imaging platforms for characterising known and recently described retinal features associated with common and rare diseases.   Speakers’ Corner, a popular feature of the Euretina Congress programme, gives

Speakers’ corner proving big hit with attendees Read More »

RETINAWS: When the going gets tough, the tough get going

Delegates filling the Auditorium on Saturday morning for the RETINAWS video course were rewarded with a valuable learning experience as top surgeons from around the world presented and discussed video excerpts showcasing complex vitreoretinal surgery, rare situations, and unique surgical techniques. The session started, however, with course director Dr Kourous Rezaei (United States) showing a

RETINAWS: When the going gets tough, the tough get going Read More »

Free Paper Winner: PULSAR trial shows efficacy of aflibercept 8 mg in wet AMD

The PULSAR trial in wet age-related macular degeneration demonstrated that aflibercept 8 mg administered every 12 or 16 weeks is noninferior in vision gains compared with aflibercept 2 mg every 8 weeks. The 60-week and 96-week outcomes of the trial were presented by Paolo Lanzetta MD, who was designated winner of the inaugural August Deutman

Free Paper Winner: PULSAR trial shows efficacy of aflibercept 8 mg in wet AMD Read More »

Specialists delve deep to unravel retinal mysteries

Everybody loves a good detective mystery and retinal specialists are no exception.  At the Medical Retina Mystery Cases session, the assembled audience was presented with a wide variety of puzzling case studies which highlighted the complex process of arriving at a correct diagnosis. Opening the session, Srinivas Sadda MD presented the intriguing case of a

Specialists delve deep to unravel retinal mysteries Read More »

EVER Symposium: Defusing the ticking timebomb of high myopia

If current trends continue, one out of every two people on the planet will be myopic by the year 2050. Even more worryingly, a significant proportion of these will be highly myopic with all the associated problems that entails in terms of ocular morbidity, disease and vision loss, according to a number of speakers at

EVER Symposium: Defusing the ticking timebomb of high myopia Read More »